Clinical research is hard enough. Your technology partnerships shouldn’t make it harder.
That’s the problem we kept hearing from CROs: they were juggling multiple eClinical vendors, each with different pricing, support teams, and contracts. Their sponsors wanted simplicity, but the CRO was stuck playing middleman. This creates friction for everyone—the CRO, the sponsor, and the sites.
Small-to-midsize CROs feel this pain most acutely. They don’t have resources to manage sprawling vendor networks, but their clients still expect a seamless experience. They need a partner who can grow with them, not an enterprise vendor that treats them like an afterthought.
That’s why we built the OpenClinica CRO Partner Program: wholesale pricing, dedicated training, joint marketing resources, and the tools to deliver our complete eClinical platform (EDC, eConsent, eCOA, Randomization, EHR-to-EDC, Reporting & Analytics, and Recruit) without vendor sprawl.
Meet Our Inaugural Partner: Endpoint Strategy
Endpoint Strategy is a boutique clinical consulting firm that works with small MedTech companies who are often navigating their first clinical trials. Co-founders Sharon Branch and Dr. Michael Conditt built Endpoint around a simple premise: remove friction from clinical research.
Sharon spent years in the medical device industry watching trials get bogged down in bureaucracy. “CROs were charging millions of dollars for any trial. Everything was so rigid. Want to make a protocol change? They’d file a form, take weeks to route it, and bill you a change fee in the process. It was very stuffy.”
She saw a gap: small MedTech companies with great technology but limited budgets. They couldn’t afford multi-million-dollar CROs or hire full-time research employees, but they needed well-structured trials to commercialize their innovations.
“Small MedTech companies have great technology, but they need clinical data—whether pre-market or post-market—to successfully commercialize,” Sharon explained. “They couldn’t afford million-dollar CROs or full-time research staff. So I said, ‘What if we just work as a team on a much more personal level?'”
Endpoint’s model is built on flexibility. “When a small company works with a small company, everyone is less rigid,” Sharon said. “We move faster. We can pivot. We work together. We tailor our process for each client in a way that delivers the most value for their clinical needs. Clinical research is not one-size-fits-all. We’re much more dynamic.”
The OpenClinica Connection
Sharon first encountered OpenClinica during an EDC evaluation in a previous role. When she launched Endpoint, her clients were using spreadsheets and paper for data collection. She knew there was a better way.
Today, nearly all of Endpoint’s clients with active clinical trials use OpenClinica, often with eConsent and Reporting & Analytics. Over half of Endpoint’s studies also use eCOA for patient-reported outcomes.
“Most of my clients have never done a clinical trial before, and it can be very overwhelming to them,” Sharon said. “When we have that first conversation, I explain: ‘In the past, it was packs of paper, three-part copies, mailing things everywhere. Then it became endless spreadsheets. That’s not ideal for the FDA anymore. EDC is how we do studies now. Endpoint will set up your database, and I’ll show you how it works, and we can manage it day to day. We make everything simple and streamlined.’ Our clients enjoy that they are not only getting an EDC system, they are getting trained experts along with it.”
Sharon doesn’t make EDC optional. She makes it simple. And for years, she’s been helping her clients adopt OpenClinica because it works for the small MedTech companies she serves.
Why This Partnership Works
The Partner Program lets Endpoint offer their clients something valuable: significant cost savings compared to working with OpenClinica independently, combined with hands-on setup and support.
“When I talk to prospective clients now, I tell them: ‘We’re experts on OpenClinica’s platform. You don’t have to spend time or money getting us up to speed—we can set you up right away. And through our partnership, we can offer you a significant discount.'”
That combination—easy setup, cleaner data, trusted results, and transparent pricing—is exactly what growing MedTech companies need to get FDA clearance.
The Partner Program also gives Endpoint access to advanced training, ongoing support, and the full OpenClinica product suite. This means Sharon’s team can deliver efficient and high-level management of the entire eClinical platform, positioning them as a strategic partner.
Endpoint Strategy embodies what we’re trying to enable with this program: a nimble, client-focused CRO that removes friction from clinical trials by combining strategic expertise with the right technology.
Interested in Joining the Program?
We’re expanding the CRO Partner Program and invite CROs to apply who:
- Value flexible, responsive partnerships over rigid vendor relationships
- Want to deliver a unified eClinical platform to clients without vendor sprawl
- Are ready to invest in training and joint marketing
Ready to learn more? Get in touch.
About Endpoint Strategy
Endpoint Strategy is a boutique clinical consulting firm co-founded by industry veterans Sharon Branch and Dr. Michael Conditt to deliver a smarter, more personalized approach to clinical research operations for MedTech innovators. With over 50 years of combined experience spanning sponsor, site, and CRO perspectives, Endpoint Strategy specializes in removing friction from clinical trials—from FDA clearance support to end-to-end trial management. The company has guided 50+ successful clinical projects for small-to-medium MedTech organizations, providing tailored strategies designed to streamline development and bring innovative technologies to market faster. Endpoint Strategy’s comprehensive services include trial design, CRF design, EDC system setup, site management, database management, day to day trial oversight, and regulatory compliance support—all built on a foundation of trust, transparency, and practical execution. Learn more at https://endpointstrategy.com/.
